| 000 | 01078 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250518055706.0 | ||
| 008 | ####s 0 0 eng d | ||
| 022 | _a2352-5789 | ||
| 024 | 7 |
_a10.1016/j.gore.2019.07.010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLee, Elizabeth K | |
| 245 | 0 | 0 |
_aResults of an abbreviated Phase Ib study of the HDAC6 inhibitor ricolinostat and paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal cancer. _h[electronic resource] |
| 260 |
_bGynecologic oncology reports _cAug 2019 |
||
| 300 |
_a118-122 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 700 | 1 | _aTan-Wasielewski, Zhenying | |
| 700 | 1 | _aMatulonis, Ursula A | |
| 700 | 1 | _aBirrer, Michael J | |
| 700 | 1 | _aWright, Alexi A | |
| 700 | 1 | _aHorowitz, Neil | |
| 700 | 1 | _aKonstantinopoulos, Panagiotis A | |
| 700 | 1 | _aCurtis, Jennifer | |
| 700 | 1 | _aLiu, Joyce F | |
| 773 | 0 |
_tGynecologic oncology reports _gvol. 29 _gp. 118-122 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.gore.2019.07.010 _zAvailable from publisher's website |
| 999 |
_c30059869 _d30059869 |
||